# Nuclide record nct06369831 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06369831/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06369831", "NCT06369831" ;
  schema:name "HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011"@en ;
  schema:alternateName "HERMIA"@en ;
  schema:description "A phase 2 trial of an investigational treatment in advanced solid tumours, run by Abscint NV/SA, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06369831/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06369831> ;
  nuclide:status "recruiting" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "2" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:targets <https://nuclide.cc/targets/her2/> .